Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Net Margin (2024)

Zentalis Pharmaceuticals has reported Net Margin over the past 1 years, most recently at 176.71% for Q4 2024.

  • For Q4 2024, Net Margin changed N/A year-over-year to 176.71%; the TTM value through Sep 2025 reached 555.8%, down 11339.0%, while the annual FY2024 figure was 246.0%, N/A changed from the prior year.
  • Net Margin for Q4 2024 was 176.71% at Zentalis Pharmaceuticals, down from 24.75% in the prior quarter.
  • Over five years, Net Margin peaked at 24.75% in Q1 2024 and troughed at 176.71% in Q4 2024.